Page 103 - scheppingen

DYSREGULATION OF THE (IMMUNO)PROTEASOME PATHWAY IN MCD
25. Prabowo AS, van Scheppingen J, Iyer AM, et al. Differential expression and clinical significance of three inflammation-related microRNAs in gangliogliomas. J Neuroinflammation. 2015;12:97.
26. Iyer A, van Scheppingen J, Anink J, Milenkovic I, Kovacs GG, Aronica E. Developmental patterns of DR6 in normal human hippocampus and in Down syndrome. Journal of neurodevelopmental disorders. 2013;5(1):10.
27. Ravizza T, Boer K, Redeker S, et al. The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiology of disease. 2006 Oct;24(1):128-43.
28. Aronica E, Gorter JA, Rozemuller AJ, Yankaya B, Troost D. Interleukin-1 beta down-regulates the expression of metabotropic glutamate receptor 5 in cultured human astrocytes. Journal of Neuroimmunology. 2005;160(1-2):188-94.
29. Iyer A, Zurolo E, Prabowo A, et al. MicroRNA-146a: a key regulator of astrocyte-mediated inflam- matory response. PloS one. 2012;7(9):e44789.
30. Zurolo E, de Groot M, Iyer A, et al. Regulation of Kir4.1 expression in astrocytes and astrocytic tumors: a role for interleukin-1 beta. Journal of neuroinflammation. 2012 Dec 28;9(1):280.
31. Ramakers C, Ruijter JM, Deprez RH, Moorman AF. Assumption-free analysis of quantitative real- time polymerase chain reaction (PCR) data. Neuroscience Letters. 2003;339(1):62-6.
32. Ruijter JM, Ramakers C, Hoogaars WM, et al. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic acids research. 2009 Apr;37(6):e45.
33. Palmini A, Najm I, Avanzini G, et al. Terminology and classification of the cortical dysplasias. Neurology. 2004 Mar 23;62(6 Suppl 3):S2-8.
34. Boer K, Jansen F, Nellist M, et al. Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy research. 2008 Jan;78(1):7-21.
35. Iyer A, Zurolo E, Spliet WG, et al. Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Epilepsia. 2010 Sep;51(9):1763-73.
36. Vezzani A, Aronica E, Mazarati A, Pittman QJ. Epilepsy and brain inflammation. Experimental neu- rology. 2013 Jun;244:11-21.
37. Wojcik C, DeMartino GN. Intracellular localization of proteasomes. Int J Biochem Cell Biol. 2003 May;35(5):579-89.
38. Ding Q, Keller JN. Proteasomes and proteasome inhibition in the central nervous system. Free Radic Biol Med. 2001 Sep 1;31(5):574-84.
39. Kremer M, Henn A, Kolb C, et al. Reduced immunoproteasome formation and accumulation of immunoproteasomal precursors in the brains of lymphocytic choriomeningitis virus-infected mice. J Immunol. 2010 Nov 1;185(9):5549-60.
40. Wehenkel M, Ban JO, Ho YK, Carmony KC, Hong JT, Kim KB. A selective inhibitor of the immuno- proteasome subunit LMP2 induces apoptosis in PC-3 cells and suppresses tumour growth in nude mice. Br J Cancer. 2012 Jun 26;107(1):53-62.
41. Hegde AN, Upadhya SC. Proteasome and transcription: a destroyer goes into construction. Bioessays. 2006 Mar;28(3):235-9.
42. Kodadek T. No Splicing, no dicing: non-proteolytic roles of the ubiquitin-proteasome system in transcription. J Biol Chem. 2010 Jan 22;285(4):2221-6.
43. McCarthy MK, Weinberg JB. The immunoproteasome and viral infection: a complex regulator of inflammation. Front Microbiol. 2015;6:21.
44. van Deventer S, Neefjes J. The Immunoproteasome Cleans up after Inflammation. Cell. 2010 Aug 20;142(4):517-8.
45. Iyer A, Zurolo E, Spliet WGM, et al. Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Epilepsia. 2010;51(9):1763-73.
46. Boer K, Jansen F, Nellist M, et al. Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy research. 2008 Jan;78(1):7-21.
47. Boer K, Crino PB, Gorter JA, et al. Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors. Brain Pathol. 2010 Jul;20(4):704-19.
48. Prabowo AS, Anink JJ, Lammens M, et al. Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation. Brain pathology. 2013 Jan;23(1):45-59.
49. Ebstein F, Kloetzel PM, Kruger E, Seifert U. Emerging roles of immunoproteasomes beyond MHC class I antigen processing. Cell Mol Life Sci. 2012 Aug;69(15):2543-58.
101
four